Future Financial Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5
Closed -$1K 339
2022
Q1
$1K Hold
5
﹤0.01% 501
2021
Q4
$1K Buy
+5
New +$1.46K ﹤0.01% 512

Other funds holding MRNA

Future Financial Wealth Management's MRNA Position: Q2 2022 in Review

Future Financial Wealth Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 5 shares — an estimated $1K sold.

Future Financial Wealth Management first reported a position in MRNA in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Future Financial Wealth Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Future Financial Wealth Management sold 5 Moderna shares in Q2 2022, an estimated $1K.
  • Future Financial Wealth Management first reported a position in Moderna in Q4 2021 and held it in 2 quarters.
  • Future Financial Wealth Management's Moderna position peaked at $1K in Q1 2022.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Future Financial Wealth Management's 13F filing for Q2 2022, filed 5 Jul 2022.